Roger Franklin has extensive experience in the life sciences industry, with over a decade spent in strategy consulting, investment banking and venture capital. Prior to his business career, Roger completed his academic training in biochemistry at Oxford University and specialized in oncology during his doctoral research at Cambridge’s Laboratory of Molecular Biology (LMB).
